Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Signs of Alzheimer's Seen Earlier Than Thought

Second study found that individuals who were informed about their risk weren't devastated

By Randy Dotinga
HealthDay Reporter


Related Encyclopedia
 border=
Acoustic Neurinoma
Alzheimer's Disease
Bell's Palsy
Brain and Spinal Cord Magnetic Resonance Imaging
More...

Related Healthscout Videos
 border=
Shutting Down Tremor.
What's Your Stroke IQ?
Disaster Heart Attacks
Weighted Belt for Autism?
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Erectile Dysfunction
What is a Heart Attack?
More...

Related Drug Information
 border=
Actonel
Adderal XR
Concerta
Coumadin
More...

Related News Articles
 border=
Deadly Stomach Bug Making Inroads Outside Hospitals
Sugar Shortens Life Span in Worms
CDC Finds U.S. 30th in Infant Mortality
Statins May Worsen Fatigue in Heart Failure Patients
More...

WEDNESDAY, July 15 (HealthDay News) -- Giving scientists insight into the origins of a devastating illness, new research suggests that people with a genetic propensity to develop Alzheimer's disease start experiencing memory loss as early as their 50s.

Unfortunately, scientists don't know of any way to prevent Alzheimer's. But an accompanying study finds that nearly everyone told of their high genetic risk of the disease was glad that they had been informed.

Text Continues Below



"In a small group, we didn't find a lot of harm done," said study author Dr. Robert Green, an Alzheimer's specialist. Even those who were told they have a 72 percent risk of developing the disease didn't tend to be devastated by the news, Green said.

Alzheimer's disease affects an estimated 5.3 million Americans, and the numbers are expected to grow as the population ages. There's no cure, although some treatments may reduce the severity of symptoms.

Scientists have known for some time that a genetic variation greatly boosts the risk of the disease, but it's still not clear how early the illness begins.

In one of the new studies, researchers looked at the genetic profiles of 815 volunteers aged 21 to 97.

Of those, 498 were at a normal genetic risk of developing Alzheimer's and 317 were at higher risk because of variations in a gene known as APOE. Of those in the latter group, 79 were at especially high risk.

The researchers gave cognitive tests to the volunteers over several years to see if there were any differences between the groups. The results appear in the July 16 issue of the New England Journal of Medicine.

The researchers found that those at higher risk of Alzheimer's began to score worse on the tests beginning in their mid-50s.

"Normally, your scores improve," explained study author Dr. Richard Caselli. "We saw that there was some improvement early on in their 40s and early 50s, but that beginning in their mid-50s we started to see changes. They weren't improving, but were beginning to decline over time."

Page:  1 | 2 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 7/15/2009

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.





SOURCES: Robert Green, M.D., MPH, co-director, Alzheimer's Disease Clinical & Research Program, Boston University; Richard Caselli, M.D., clinical core director, Arizona Alzheimer's Disease Center, and chair, neurology, Mayo Clinic, Scottsdale; July 16, 2009, New England Journal of Medicine


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy